Parkinson’s disease clinical research in 7MM focuses on disease-modifying agents: GlobalData EP News Bureau Nov 11, 2024 The 7MM pipeline in Parkinson’s disease shifts focus to neuroprotective and disease-modifying therapies, aiming to address unmet…
Cellectricon’s new neuroinflammation discovery services offer advanced insight into chronic pain EP News Bureau May 21, 2020 Cellectricon will grant Clients long-term partnerships focusing on the development of novel in vitro models to better understand…
